Paper32320006
Nicotinamide riboside supplementation alters body composition and skeletal muscle acetylcarnitine concentrations in healthy obese humans.
Remie CME and 19 others. Am J Clin Nutr, 2020. Cited by 136 papers, by iCite.
Cite this record
ConductScience Library. Nicotinamide riboside supplementation alters body composition and skeletal muscle acetylcarnitine concentrations in healthy obese humans. Papers, record 32320006. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32320006
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Acetylcarnitine | Major topic |
| Body Composition | Major topic |
| Muscle, Skeletal | Major topic |
| Niacinamide | Major topic |
| Obesity | Major topic |
| Overweight | Major topic |
| Aged | |
| Dietary Supplements | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| NAD | |
| Pyridinium Compounds |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT02835664 | Nicotinamide Riboside and Metabolic Health | Derived from the trial | Yes |
Source ClinicalTrials.gov
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 32412605 | Fat mobilization without weight loss is a potentially rapid response to nicotinamide riboside in obese people: it's time to test with exercise. | https://conductscience.org/library/papers/32412605 |
Source PubMed
References51
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1645211 | Table of nonprotein respiratory quotient: an update. | Can J Sport Sci | 1991 | https://conductscience.org/library/papers/1645211 | PubMed |
| 2 | 27230286 | Nicotinamide Riboside Opposes Type 2 Diabetes and Neuropathy in Mice. | Sci Rep | 2016 | https://conductscience.org/library/papers/27230286 | PubMed |
| 3 | 27552971 | Slowing ageing by design: the rise of NAD+ and sirtuin-activating compounds. | Nat Rev Mol Cell Biol | 2016 | https://conductscience.org/library/papers/27552971 | PubMed |
| 4 | 28752046 | Nicotinamide riboside kinases display redundancy in mediating nicotinamide mononucleotide and nicotinamide riboside metabolism in skeletal muscle cells. | Mol Metab | 2017 | https://conductscience.org/library/papers/28752046 | PubMed |
| 5 | 27053384 | Long-term magnesium supplementation improves arterial stiffness in overweight and obese adults: results of a randomized, double-blind, placebo-controlled intervention trial. | Am J Clin Nutr | 2016 | https://conductscience.org/library/papers/27053384 | PubMed |
| 6 | 17452617 | Ambulatory blood pressure for cardiovascular risk stratification. | Circulation | 2007 | https://conductscience.org/library/papers/17452617 | PubMed |
| 7 | 31207144 | Aerobic and resistance exercise training reverses age-dependent decline in NAD+ salvage capacity in human skeletal muscle. | Physiol Rep | 2019 | https://conductscience.org/library/papers/31207144 | PubMed |
| 8 | 21102553 | Measurement of longitudinal changes in body composition during weight loss and maintenance in overweight and obese subjects using air-displacement plethysmography in comparison with the deuterium dilution technique. | Int J Obes (Lond) | 2011 | https://conductscience.org/library/papers/21102553 | PubMed |
| 9 | 22106091 | Targeting sirtuin 1 to improve metabolism: all you need is NAD(+)? | Pharmacol Rev | 2012 | https://conductscience.org/library/papers/22106091 | PubMed |
| 10 | 31412242 | Nicotinamide Riboside Augments the Aged Human Skeletal Muscle NAD+ Metabolome and Induces Transcriptomic and Anti-inflammatory Signatures. | Cell Rep | 2019 | https://conductscience.org/library/papers/31412242 | PubMed |
| 11 | 15137942 | Discoveries of nicotinamide riboside as a nutrient and conserved NRK genes establish a Preiss-Handler independent route to NAD+ in fungi and humans. | Cell | 2004 | https://conductscience.org/library/papers/15137942 | PubMed |
| 12 | 20573749 | Prolonged fasting identifies skeletal muscle mitochondrial dysfunction as consequence rather than cause of human insulin resistance. | Diabetes | 2010 | https://conductscience.org/library/papers/20573749 | PubMed |
| 13 | 31491949 | Combined Treatment with L-Carnitine and Nicotinamide Riboside Improves Hepatic Metabolism and Attenuates Obesity and Liver Steatosis. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/31491949 | PubMed |
| 14 | 27508874 | Loss of NAD Homeostasis Leads to Progressive and Reversible Degeneration of Skeletal Muscle. | Cell Metab | 2016 | https://conductscience.org/library/papers/27508874 | PubMed |
| 15 | 29992272 | A randomized placebo-controlled clinical trial of nicotinamide riboside in obese men: safety, insulin-sensitivity, and lipid-mobilizing effects. | Am J Clin Nutr | 2018 | https://conductscience.org/library/papers/29992272 | PubMed |
| 16 | 29184669 | Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD+ levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study. | NPJ Aging Mech Dis | 2017 | https://conductscience.org/library/papers/29184669 | PubMed |
| 17 | 28211258 | Effects of a wide range of dietary nicotinamide riboside (NR) concentrations on metabolic flexibility and white adipose tissue (WAT) of mice fed a mildly obesogenic diet. | Mol Nutr Food Res | 2017 | https://conductscience.org/library/papers/28211258 | PubMed |
| 18 | 4044103 | Variability of aerobic performance in the laboratory and its physiologic correlates. | Int J Sports Med | 1985 | https://conductscience.org/library/papers/4044103 | PubMed |
| 19 | 4351123 | An enzymatic cycling method for nicotinamide-adenine dinucleotide with malic and alcohol dehydrogenases. | Anal Biochem | 1973 | https://conductscience.org/library/papers/4351123 | PubMed |
| 20 | 4337382 | Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. | Clin Chem | 1972 | https://conductscience.org/library/papers/4337382 | PubMed |
Cited by102
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 136 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42786201 | Cardiovascular-kidney-metabolic syndrome as a mitochondrial systems disorder. | Nat Rev Nephrol | 2026 | https://conductscience.org/library/papers/42786201 | PubMed |
| 42769337 | Myosteatosis in type 1 diabetes: immunometabolic mechanisms, biomarkers, and therapeutic targets. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/42769337 | PubMed |
| 42708068 | Precision Nanodelivery Enables Spatiotemporal Control of NAD⁺ Metabolism in Ageing and Disease. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42708068 | PubMed |
| 42521674 | Mitochondrial quality control in health and disease: mechanisms and therapeutic targets. | Signal Transduct Target Ther | 2026 | https://conductscience.org/library/papers/42521674 | PubMed |
| 42188047 | Targeting NAD Homeostasis: Compartmentalization, Quantification, and Modulation. | Metabolites | 2026 | https://conductscience.org/library/papers/42188047 | PubMed |
| 42170103 | Nicotinamide mononucleotide stimulates the activity of bursting slow-oscillation neurons in the supramammillary nucleus and enhances REM sleep. | iScience | 2026 | https://conductscience.org/library/papers/42170103 | PubMed |
| 42009009 | Safety and efficacy of individualised exercise and NAD+ precursor supplementation in patients with Friedreich's ataxia in the USA: a single-centre, 2 × 2 factorial, randomised controlled trial. | Lancet Neurol | 2026 | https://conductscience.org/library/papers/42009009 | PubMed |
| 41774222 | Nutrition's role in extending healthspan: CRN-international symposium report. | Eur J Nutr | 2026 | https://conductscience.org/library/papers/41774222 | PubMed |
| 41357333 | Effects of nicotinamide riboside on NAD+ levels, cognition, and symptom recovery in long-COVID: a randomized controlled trial. | EClinicalMedicine | 2025 | https://conductscience.org/library/papers/41357333 | PubMed |
| 41295291 | Harnessing Metabolomics to Advance Nutrition-Based Therapeutics for Inflammation: A Systematic Review of Randomized Clinical Trials. | Metabolites | 2025 | https://conductscience.org/library/papers/41295291 | PubMed |
| 41291376 | NAD + in fatty liver disease: mechanistic insights and associated targets. | Cell Biol Toxicol | 2025 | https://conductscience.org/library/papers/41291376 | PubMed |
| 41083806 | NAD+ precursor supplementation in human ageing: clinical evidence and challenges. | Nat Metab | 2025 | https://conductscience.org/library/papers/41083806 | PubMed |
| 40926126 | Emerging strategies, applications and challenges of targeting NAD+ in the clinic. | Nat Aging | 2025 | https://conductscience.org/library/papers/40926126 | PubMed |
| 40879949 | Protein Acetylation and NAD+ Homeostasis in Aging Muscle. | Adv Exp Med Biol | 2025 | https://conductscience.org/library/papers/40879949 | PubMed |
| 40867810 | Nicotinamide and Pyridoxine in Muscle Aging: Nutritional Regulation of Redox, Inflammation, and Regeneration. | Antioxidants (Basel) | 2025 | https://conductscience.org/library/papers/40867810 | PubMed |
| 40784868 | Exercise pills for cardiometabolic health cannot mimic the exercise milieu. | Trends Endocrinol Metab | 2026 | https://conductscience.org/library/papers/40784868 | PubMed |
| 40775221 | Nicotinamide phosphoribosyltransferase in NAD+ metabolism: physiological and pathophysiological implications. | Cell Death Discov | 2025 | https://conductscience.org/library/papers/40775221 | PubMed |
| 40770531 | Nicotinamide riboside combined with exercise to treat hypertension in middle-aged and older adults: a pilot randomized clinical trial. | Geroscience | 2025 | https://conductscience.org/library/papers/40770531 | PubMed |
| 40604314 | The role of NAD+ metabolism and its modulation of mitochondria in aging and disease. | NPJ Metab Health Dis | 2025 | https://conductscience.org/library/papers/40604314 | PubMed |
| 40573093 | Vitamin B3 Ameliorates Sleep Duration and Quality in Clinical and Pre-Clinical Studies. | Nutrients | 2025 | https://conductscience.org/library/papers/40573093 | PubMed |
Genes14
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32320006
GET https://conductscience.org/api/papers/v1/32320006/references?page=2